Cargando…
Recent advances in managing primary hypertension
Hypertension remains a leading risk factor for cardiovascular mortality and morbidity globally despite the availability of effective and well-tolerated antihypertensive medications. Accumulating evidence suggests a more aggressive blood pressure regulation aimed at lower targets, particularly for se...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculty Opinions Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894269/ https://www.ncbi.nlm.nih.gov/pubmed/33659936 http://dx.doi.org/10.12703/b/9-4 |
_version_ | 1783653214419156992 |
---|---|
author | Leontsinis, Ioannis Mantzouranis, Manos Tsioufis, Panagiotis Andrikou, Ioannis Tsioufis, Costas |
author_facet | Leontsinis, Ioannis Mantzouranis, Manos Tsioufis, Panagiotis Andrikou, Ioannis Tsioufis, Costas |
author_sort | Leontsinis, Ioannis |
collection | PubMed |
description | Hypertension remains a leading risk factor for cardiovascular mortality and morbidity globally despite the availability of effective and well-tolerated antihypertensive medications. Accumulating evidence suggests a more aggressive blood pressure regulation aimed at lower targets, particularly for selected patient groups. Our concepts of the optimal method for blood pressure measurement have radically changed, maintaining appropriate standard office measurements for initial assessment but relying on out-of-office measurement to better guide our decisions. Thorough risk stratification provides guidance in decision making; however, an individualized approach is highly recommended to prevent overtreatment. Undertreatment, on the other hand, remains a major concern and is mainly attributed to poor adherence and resistant or difficult-to-control forms of the disease. This review aims to present modern perspectives, novel treatment options, including innovative technological applications and developing interventional and pharmaceutical therapies, and the major concerns emerging from several years of research and epidemiological observations related to hypertension management. |
format | Online Article Text |
id | pubmed-7894269 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Faculty Opinions Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-78942692021-03-02 Recent advances in managing primary hypertension Leontsinis, Ioannis Mantzouranis, Manos Tsioufis, Panagiotis Andrikou, Ioannis Tsioufis, Costas Fac Rev Review Article Hypertension remains a leading risk factor for cardiovascular mortality and morbidity globally despite the availability of effective and well-tolerated antihypertensive medications. Accumulating evidence suggests a more aggressive blood pressure regulation aimed at lower targets, particularly for selected patient groups. Our concepts of the optimal method for blood pressure measurement have radically changed, maintaining appropriate standard office measurements for initial assessment but relying on out-of-office measurement to better guide our decisions. Thorough risk stratification provides guidance in decision making; however, an individualized approach is highly recommended to prevent overtreatment. Undertreatment, on the other hand, remains a major concern and is mainly attributed to poor adherence and resistant or difficult-to-control forms of the disease. This review aims to present modern perspectives, novel treatment options, including innovative technological applications and developing interventional and pharmaceutical therapies, and the major concerns emerging from several years of research and epidemiological observations related to hypertension management. Faculty Opinions Ltd 2020-11-04 /pmc/articles/PMC7894269/ /pubmed/33659936 http://dx.doi.org/10.12703/b/9-4 Text en Copyright: © 2020 Tsioufis C et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Leontsinis, Ioannis Mantzouranis, Manos Tsioufis, Panagiotis Andrikou, Ioannis Tsioufis, Costas Recent advances in managing primary hypertension |
title | Recent advances in managing primary hypertension |
title_full | Recent advances in managing primary hypertension |
title_fullStr | Recent advances in managing primary hypertension |
title_full_unstemmed | Recent advances in managing primary hypertension |
title_short | Recent advances in managing primary hypertension |
title_sort | recent advances in managing primary hypertension |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894269/ https://www.ncbi.nlm.nih.gov/pubmed/33659936 http://dx.doi.org/10.12703/b/9-4 |
work_keys_str_mv | AT leontsinisioannis recentadvancesinmanagingprimaryhypertension AT mantzouranismanos recentadvancesinmanagingprimaryhypertension AT tsioufispanagiotis recentadvancesinmanagingprimaryhypertension AT andrikouioannis recentadvancesinmanagingprimaryhypertension AT tsioufiscostas recentadvancesinmanagingprimaryhypertension |